A Randomized, Open-label, Single Dose, Crossover Clinical Trial to Compare the Safety and Pharmacokinetics of YH22189 in Comparison to Telmisartan/Amlodipine and Rosuvastatin in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 06 Feb 2017
At a glance
- Drugs Amlodipine/rosuvastatin/telmisartan (Primary) ; Amlodipine/telmisartan; Rosuvastatin
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Yuhan
- 18 Oct 2016 Status changed from active, no longer recruiting to discontinued as per Sponsor decesion.
- 10 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 11 Mar 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov.